{"id":"creatinine","rwe":[],"_fda":{"id":"9cfee475-afb6-479b-a552-240f97fb29a7","set_id":"20e20965-61db-44a3-82bf-f1ca18e6b6bc","openfda":{"unii":["2P3VWU3H10","6T6CO7R3Z5","28M1820ACT","1TH8Q20J0U","RFM9X3LJ49","279O8I0433","MU72812GK0","AYI8EX34EU","4VBP01X99F","P776JQ4R2F","8724FJW4M5","DJO934BRBD","324Y4038G2","2S713A4VP3","C177VR41DV","G025DAL7CE","Y3V16D4PV4","H6241UJ22B","9W945B5H7R","WYT05213GE","S61JFZ33Z1","39981FM375","QNS6W5US1Z"],"route":["ORAL"],"spl_id":["9cfee475-afb6-479b-a552-240f97fb29a7"],"brand_name":["Colotox"],"spl_set_id":["20e20965-61db-44a3-82bf-f1ca18e6b6bc"],"package_ndc":["43857-0801-1"],"product_ndc":["43857-0801"],"generic_name":["ALFALFA, BERBERIS VULGARIS, RHAMNUS PURSHIANA, RHEUM (PALMATUM), TARAXACUM OFFICINALE, HEPAR BOVINE, SMALL INTESTINE (SUIS), ARANEA DIADEMA, CARBO ANIMALIS, CARBO VEGETABILIS, CINA, MERCURIUS SOLUBILIS, PODOPHYLLUM PELTATUM, SELENIUM METALLICUM, SPIGELIA ANTHELMIA, VERATRUM ALBUM, BILIRUBIN, CREATINE, CREATININE, INDOLUM, SKATOLUM, PROTEUS (MIRABILIS), MORGAN GAERTNER"],"product_type":["HUMAN OTC DRUG"],"substance_name":["ACTIVATED CHARCOAL","ARANEUS DIADEMATUS","ARTEMISIA CINA PRE-FLOWERING TOP","BERBERIS VULGARIS ROOT BARK","BILIRUBIN","CARBO ANIMALIS","CREATINE","CREATININE","FRANGULA PURSHIANA BARK","HEPARIN, BOVINE","INDOLE","MEDICAGO SATIVA WHOLE","MERCURIUS SOLUBILIS","PODOPHYLLUM","PROTEUS MIRABILIS","RHEUM PALMATUM ROOT","SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS","SELENIUM","SKATOLE","SPIGELIA ANTHELMIA WHOLE","SUS SCROFA INTESTINAL MUCOSA","TARAXACUM OFFICINALE","VERATRUM ALBUM ROOT"],"manufacturer_name":["BioActive Nutritional, Inc."],"is_original_packager":[true]},"purpose":["PURPOSE: For temporary relief of flatulence associated with constipation."],"version":"1","warnings":["WARNINGS: If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in cool, dry place."],"questions":["QUESTIONS: Distributed by: BioActive Nutritional, Inc. 1803 N. Wickham Rd. Melbourne, FL 32935 bioactivenutritional.com"],"effective_time":"20260120","active_ingredient":["ACTIVE INGREDIENTS: Alfalfa 3X, Berberis Vulgaris 3X, Rhamnus Purshiana 3X, Rheum 3X, Taraxacum Officinale 3X, Hepar Bovine 8X, Small Intestine 8X, Aranea Diadema 12X, Carbo Animalis 12X, Carbo Vegetabilis 12X, CINA 12X, Mercurius Solubilis 12X, Podophyllum Peltatum 12X, Selenium Metallicum 12X, Spigelia Anthelmia 12X, Veratrum Album 12X, Bilirubin 15X, 30X, 200X, Creatine 15X, 30X, 200X, Creatinine 15X, 30X, 200X, Indolum 15X, 30X, 200X, Skatolum 15X, 30X, 200X, Proteus 20X, Morgan Gaertner 12C."],"inactive_ingredient":["INACTIVE INGREDIENTS: Demineralized Water, 25% Ethanol"],"indications_and_usage":["INDICATIONS: For temporary relief of flatulence associated with constipation."],"dosage_and_administration":["DIRECTIONS: 10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age."],"spl_product_data_elements":["Colotox Alfalfa, Berberis Vulgaris, Rhamnus Purshiana, Rheum (Palmatum), Taraxacum Officinale, Hepar Bovine, Small Intestine (Suis), Aranea Diadema, Carbo Animalis, Carbo Vegetabilis, CINA, Mercurius Solubilis, Podophyllum Peltatum, Selenium Metallicum, Spigelia Anthelmia, Veratrum Album, Bilirubin, Creatine, Creatinine, Indolum, Skatolum, Proteus (Mirabilis), Morgan Gaertner MEDICAGO SATIVA WHOLE ALFALFA BERBERIS VULGARIS ROOT BARK BERBERIS VULGARIS ROOT BARK FRANGULA PURSHIANA BARK FRANGULA PURSHIANA BARK RHEUM PALMATUM ROOT RHEUM PALMATUM ROOT TARAXACUM OFFICINALE TARAXACUM OFFICINALE HEPARIN, BOVINE HEPARIN, BOVINE SUS SCROFA INTESTINAL MUCOSA SUS SCROFA INTESTINAL MUCOSA ARANEUS DIADEMATUS ARANEUS DIADEMATUS CARBO ANIMALIS CARBO ANIMALIS ACTIVATED CHARCOAL ACTIVATED CHARCOAL ARTEMISIA CINA PRE-FLOWERING TOP ARTEMISIA CINA FLOWER MERCURIUS SOLUBILIS MERCURIUS SOLUBILIS PODOPHYLLUM PODOPHYLLUM SELENIUM SELENIUM SPIGELIA ANTHELMIA WHOLE SPIGELIA ANTHELMIA VERATRUM ALBUM ROOT VERATRUM ALBUM ROOT BILIRUBIN BILIRUBIN CREATINE CREATINE CREATININE CREATININE INDOLE INDOLE SKATOLE SKATOLE PROTEUS MIRABILIS PROTEUS MIRABILIS SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS WATER ALCOHOL"],"keep_out_of_reach_of_children":["KEEP OUT OF REACH OF CHILDREN: In case of overdose, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["PACKAGE LABEL DISPLAY: Bio Active Nutritional COLOTOX HOMEOPATHIC 1 FL OZ (30 ml) image description"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Active","category":"status"},{"label":"flatulence associated with constipation","category":"indication"},{"label":"BioActive Nutritional, Inc.","category":"company"}],"phase":"marketed","safety":{"boxedWarnings":[]},"trials":[],"aliases":[],"company":"BioActive Nutritional, Inc.","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CREATININE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:17:56.901156+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Creatinine","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T00:18:05.361743+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:18:03.910535+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CREATININE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:18:04.770485+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:17:54.675030+00:00"},"indications.approved":{"url":"","method":"ai_extraction","source":"FDA Label + AI","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:18:11.948747+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:17:54.675079+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL65567/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:05.246401+00:00"}},"allNames":"colotox","offLabel":[],"synonyms":["Colotox","ACTIVATED CHARCOAL"],"timeline":[],"approvals":[],"brandName":"Colotox","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Colotox, or creatinine, is a small molecule that is involved in the breakdown of waste products in the body, particularly in the kidneys. It is thought to play a role in the urea cycle, where it helps to convert waste products into less toxic compounds that can be excreted from the body."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Creatinine","title":"Creatinine","extract":"Creatinine is a breakdown product of creatine phosphate from muscle and protein metabolism. It is released at a constant rate by the body."},"commercial":{},"references":[{"id":1,"url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:\"CREATININE\"","fields":["mechanism","indications","adverse_reactions","contraindications","warnings","dosage"],"source":"OpenFDA Label"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=creatinine","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=creatinine","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Creatinine","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-31T10:18:11.664171","_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:18:12.214232+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"creatinine","indications":{"approved":[{"id":"creatinine-flatulence-relief","name":"Flatulence relief","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Individuals experiencing flatulence associated with constipation","pivotalTrial":null,"restrictions":[],"patientPopulation":"Individuals experiencing flatulence associated with constipation","diagnosticRequired":null,"brandNameForIndication":"Colotox"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06292377","phase":"NA","title":"Better Understanding of Fatigue After STroke","status":"RECRUITING","sponsor":"Brugmann University Hospital","startDate":"2024-06-07","conditions":["Stroke"],"enrollment":250,"completionDate":"2027-12-31"},{"nctId":"NCT05454579","phase":"","title":"The South-East Asian Transgender Health Cohort","status":"COMPLETED","sponsor":"Institute of HIV Research and Innovation Foundation, Thailand","startDate":"2022-12-02","conditions":["HIV","STIs","HCV"],"enrollment":450,"completionDate":"2025-03-30"},{"nctId":"NCT07487506","phase":"NA","title":"Evaluation and Assessment for Communicable Diseases in Migrants Hosted in Reception Centers","status":"RECRUITING","sponsor":"IRCCS Sacro Cuore Don Calabria di Negrar","startDate":"2025-04-08","conditions":["Infections"],"enrollment":250,"completionDate":"2026-09-08"},{"nctId":"NCT06018831","phase":"NA","title":"Urine and Ultrasound Screening for Kidney Disease in Children","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2022-04-12","conditions":["Kidney Diseases","Diagnostic Techniques","Ultrasound","Urinalysis","Child, Only"],"enrollment":13000,"completionDate":"2028-02"},{"nctId":"NCT03228459","phase":"NA","title":"The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut de Recerca Biomèdica de Lleida","startDate":"2015-01-15","conditions":["Atherosclerosis","Chronic Kidney Diseases","Metabolic Syndrome","PreDiabetes","Subclinical Disease and/or Syndrome"],"enrollment":16660,"completionDate":"2028-12-31"},{"nctId":"NCT07493655","phase":"NA","title":"Therapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus Nephritis","status":"NOT_YET_RECRUITING","sponsor":"Federal University of Maranhao","startDate":"2026-07-01","conditions":["Systemic Lupus Erythematosus","Lupus Nephritis","Drug Monitoring","Mycophenolic Acid"],"enrollment":100,"completionDate":"2028-12-31"},{"nctId":"NCT07490808","phase":"NA","title":"Peri-procedural Hydration to Prevent Acute Kidney Injury After Pulsed Field Ablation for Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2026-03","conditions":["Atrial Fibrillation (AF)","Acute Kidney Injury"],"enrollment":290,"completionDate":"2026-10"},{"nctId":"NCT02199145","phase":"NA","title":"Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2015-07-17","conditions":["Membranous Nephropathy"],"enrollment":52,"completionDate":"2020-06-04"},{"nctId":"NCT04417088","phase":"PHASE1,PHASE2","title":"Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy","status":"COMPLETED","sponsor":"InSightec","startDate":"2020-11-06","conditions":["Recurrent Glioblastoma"],"enrollment":28,"completionDate":"2023-12-31"},{"nctId":"NCT05268289","phase":"PHASE2","title":"Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-08-10","conditions":["Lupus Nephritis"],"enrollment":240,"completionDate":"2028-09-28"},{"nctId":"NCT07024823","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-06-09","conditions":["Chronic Kidney Disease"],"enrollment":124,"completionDate":"2026-06-18"},{"nctId":"NCT06678685","phase":"PHASE2,PHASE3","title":"Spironolactone Improved Children With Gene Mutations Related to NCOR","status":"COMPLETED","sponsor":"Qilu Hospital of Shandong University","startDate":"2024-10-30","conditions":["NCOR Gene Mutations","Spironolactone","ASD"],"enrollment":2,"completionDate":"2025-10-30"},{"nctId":"NCT05100862","phase":"PHASE3","title":"A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma","status":"RECRUITING","sponsor":"BeiGene","startDate":"2022-03-10","conditions":["Relapsed/Refractory Follicular Lymphoma","Marginal Zone Lymphoma"],"enrollment":780,"completionDate":"2030-06"},{"nctId":"NCT07268638","phase":"PHASE2","title":"A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)","status":"RECRUITING","sponsor":"Akebia Therapeutics","startDate":"2025-12-03","conditions":["Focal Segmental Glomerulosclerosis"],"enrollment":60,"completionDate":"2028-01"},{"nctId":"NCT07469722","phase":"PHASE2,PHASE3","title":"POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2026-03-23","conditions":["Acute Heart Failure (AHF)","Congestive Heart Failure Acute","Diuretic Effect","Lung Ultrasonography Score","Ultrasonography, Doppler","Point-of-care Ultrasound (POCUS)"],"enrollment":128,"completionDate":"2028-07-01"},{"nctId":"NCT07476248","phase":"","title":"The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-10-01","conditions":["Diabetic Nephropathy","Dyslipidemia"],"enrollment":84,"completionDate":"2027-12-01"},{"nctId":"NCT01248429","phase":"","title":"Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2010-11","conditions":["Cancer","Solid Tumor"],"enrollment":154,"completionDate":"2013-01-15"},{"nctId":"NCT04151667","phase":"PHASE2","title":"Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-11-22","conditions":["Multiple Myeloma"],"enrollment":33,"completionDate":"2026-05-07"},{"nctId":"NCT07458191","phase":"","title":"Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation","status":"RECRUITING","sponsor":"Bosnalijek D.D","startDate":"2025-10-09","conditions":["Nonvalvular Atrial Fibrillation"],"enrollment":800,"completionDate":"2027-04"},{"nctId":"NCT07460908","phase":"NA","title":"Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome","status":"COMPLETED","sponsor":"Lahore General Hospital","startDate":"2025-05-01","conditions":["Hepatorenal Syndrome"],"enrollment":60,"completionDate":"2025-10-30"},{"nctId":"NCT04953897","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment","status":"RECRUITING","sponsor":"Taiho Oncology, Inc.","startDate":"2021-12-15","conditions":["Acute Myeloid Leukemia","Myelodysplastic Syndromes"],"enrollment":18,"completionDate":"2026-12"},{"nctId":"NCT06059846","phase":"PHASE3","title":"A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)","status":"COMPLETED","sponsor":"Spero Therapeutics","startDate":"2023-12-21","conditions":["Urinary Tract Infection","Acute Pyelonephritis"],"enrollment":1690,"completionDate":"2025-02-06"},{"nctId":"NCT04002531","phase":"NA","title":"A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children","status":"COMPLETED","sponsor":"Baylor Research Institute","startDate":"2018-11-10","conditions":["Quality of Life","Renal Insufficiency","Cardiac Event"],"enrollment":5,"completionDate":"2019-12-13"},{"nctId":"NCT06576076","phase":"NA","title":"Cannabis, Linked Emotions, and Adolescent Risk Study","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-02-18","conditions":["Cannabis Use","Depression","Suicidal Ideation","Adolescent Behavior"],"enrollment":200,"completionDate":"2029-04-30"},{"nctId":"NCT07116330","phase":"","title":"Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment","status":"RECRUITING","sponsor":"Sahlgrenska University Hospital","startDate":"2025-09-01","conditions":["Epilepsy","Seizure"],"enrollment":420,"completionDate":"2035-06"},{"nctId":"NCT07441811","phase":"","title":"Urine Albumin/Creatinine Ratio and Renal Function Differences in Phenotypes of Polycystic Ovary Syndrome.","status":"COMPLETED","sponsor":"Uşak University","startDate":"2022-04-01","conditions":["Polycystic Ovary Syndrome","Urine Albumin \\(UAlb\\)","Urine Creatinine \\(UCr\\)","Glomerular Filtration Rate"],"enrollment":300,"completionDate":"2023-07-20"},{"nctId":"NCT04224493","phase":"PHASE3","title":"A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.","status":"RECRUITING","sponsor":"Epizyme, Inc.","startDate":"2020-06-11","conditions":["Relapsed/Refractory Follicular Lymphoma","Follicular Lymphoma","Refractory Follicular Lymphoma"],"enrollment":612,"completionDate":"2029-03-01"},{"nctId":"NCT07442552","phase":"","title":"Perioperative Sepsis. An Epigenetic Perspective","status":"RECRUITING","sponsor":"Carol Davila University of Medicine and Pharmacy","startDate":"2026-01-20","conditions":["Sepsis Abdominal"],"enrollment":40,"completionDate":"2026-04-10"},{"nctId":"NCT07224776","phase":"PHASE1","title":"Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-03-01","conditions":["Proteinuric Renal Disease","Proteinuric Kidney Disease","Proteinuria","Proteinuria in Nephrotic Range"],"enrollment":20,"completionDate":"2028-12-01"},{"nctId":"NCT07106151","phase":"NA","title":"Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-02-23","conditions":["AKI","AKI - Acute Kidney Injury","Dialysis Patients"],"enrollment":40,"completionDate":"2028-01"},{"nctId":"NCT07139626","phase":"","title":"Screening of Predictive Biomarkers for Cardiorenal Syndrome","status":"RECRUITING","sponsor":"Haiyan Pan","startDate":"2025-09-15","conditions":["Cardiorenal Syndrome (CRS)"],"enrollment":150,"completionDate":"2027-12-31"},{"nctId":"NCT07440095","phase":"","title":"Mortality Predictors in Patients 80+ After Major Abdominal Surgery: Role of Frailty and Physiological Reserve","status":"NOT_YET_RECRUITING","sponsor":"Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital","startDate":"2026-03-01","conditions":["Frailty","Postoperative Complications","Aged, 80 and Over","Abdomen Cancer"],"enrollment":200,"completionDate":"2026-04-10"},{"nctId":"NCT07427069","phase":"","title":"Chronic Kidney Disease Associated Diet","status":"NOT_YET_RECRUITING","sponsor":"Recep Tayyip Erdogan University Training and Research Hospital","startDate":"2026-04-20","conditions":["Chronic Kidney Disease","Periodontitis","Diet, Food and Nutrition"],"enrollment":100,"completionDate":"2026-11-16"},{"nctId":"NCT06561477","phase":"","title":"Role of ICCO Score in Predicting Outcome in ICU Patients","status":"COMPLETED","sponsor":"Assiut University","startDate":"2025-03-01","conditions":["Liver Cirrhosis"],"enrollment":150,"completionDate":"2026-02-06"},{"nctId":"NCT07292493","phase":"","title":"Immune System in Diabetic Kidney Disease","status":"ENROLLING_BY_INVITATION","sponsor":"University Medical Centre Ljubljana","startDate":"2025-12-01","conditions":["Diabetes","Diabetic Kidney Disease","Complement System"],"enrollment":90,"completionDate":"2028-12"},{"nctId":"NCT07422974","phase":"","title":"Perioperative Outcomes After Neoadjuvant Therapy in Colorectal Cancer","status":"RECRUITING","sponsor":"Osijek University Hospital","startDate":"2026-01-09","conditions":["Colorectal Carcinoma (CRC)","Complications","Neoadjuvant Therapy","Endothelial Dysfunction"],"enrollment":68,"completionDate":"2027-05-01"},{"nctId":"NCT06840210","phase":"","title":"Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-04-01","conditions":["Acute Kidney Injury"],"enrollment":200000,"completionDate":"2030-12-01"},{"nctId":"NCT07410624","phase":"","title":"Augmented Renal Clearance in Neurocritical Care","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2021-10-01","conditions":["TBI (Traumatic Brain Injury)","Status Epilepticus","Bacterial Meningitis","Augmented Renal Clearance (ARC)","Subarachnoid Hemorrhage, Aneurysmal","Ischemic Stroke","Intracerebral Hemorrhage"],"enrollment":512,"completionDate":"2026-09-30"},{"nctId":"NCT07412366","phase":"","title":"Urea-to-Creatinine Ratio as a Marker of Metabolic Transition in Septic Shock: A Comparison With Indirect Calorimetry","status":"NOT_YET_RECRUITING","sponsor":"Hospital Sao Domingos","startDate":"2026-04-01","conditions":["Septic Shock"],"enrollment":40,"completionDate":"2027-10"},{"nctId":"NCT06094920","phase":"PHASE4","title":"Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2024-07-29","conditions":["Diabetes Mellitus Type 2 With Proteinuria","Diabetes Mellitus, Type 2","Diabetes Mellitus","Diabetes","Diabetes Complications","Albuminuria","Chronic Kidney Diseases","Chronic Kidney Disease Due to Type 2 Diabetes Mellitus","Chronic Kidney Disease stage3","Chronic Kidney Disease stage4","CKD","CKD Stage 3","CKD Stage 4"],"enrollment":12,"completionDate":"2025-09-24"},{"nctId":"NCT07287345","phase":"PHASE4","title":"Colchicine's Effect on Inflammatory Markers","status":"RECRUITING","sponsor":"Ayesha Ather","startDate":"2026-01-16","conditions":["Colchicine","Inflammation in Cardiac Surgery","Post Operative Atrial Fibrillation","Inflammatory Markers","Colchicine Adverse Reaction"],"enrollment":24,"completionDate":"2026-06"},{"nctId":"NCT03907046","phase":"PHASE3","title":"Anticoagulation in ICH Survivors for Stroke Prevention and Recovery","status":"RECRUITING","sponsor":"Yale University","startDate":"2020-01-28","conditions":["Intracerebral Hemorrhage","Atrial Fibrillation"],"enrollment":700,"completionDate":"2027-04"},{"nctId":"NCT07397689","phase":"","title":"Early Sepsis Recognition Tool","status":"NOT_YET_RECRUITING","sponsor":"KK Women's and Children's Hospital","startDate":"2026-02","conditions":["Infection","Sepsis"],"enrollment":40000,"completionDate":"2028-12"},{"nctId":"NCT05651880","phase":"PHASE3","title":"Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2026-03","conditions":["Active Non-anterior Non-infectious Uveitis"],"enrollment":33,"completionDate":"2029-08"},{"nctId":"NCT04776486","phase":"NA","title":"Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-09-03","conditions":["Augmented Renal Clearance","Critically Ill"],"enrollment":90,"completionDate":"2026-01-29"},{"nctId":"NCT06202235","phase":"","title":"Multifrequency MRE in Evaluation of Chronic Kidney Diseases","status":"RECRUITING","sponsor":"Shengjing Hospital","startDate":"2022-10-10","conditions":["Chronic Kidney Disease (CKD)"],"enrollment":200,"completionDate":"2027-06-08"},{"nctId":"NCT06953726","phase":"PHASE4","title":"Comparing the Safety and Efficacy of Apixaban and Rivaroxaban","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-03-30","conditions":["Atrial Fibrillation"],"enrollment":10000,"completionDate":"2033-10-03"},{"nctId":"NCT07287332","phase":"NA","title":"BLOOM: Pragmatic Feasibility Trial","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-01-15","conditions":["Sepsis","Infection"],"enrollment":300,"completionDate":"2027-07"},{"nctId":"NCT07392710","phase":"NA","title":"Clinical Evaluation of the Nova Max Pro StatSensor Device","status":"COMPLETED","sponsor":"Royal Free Hospital NHS Foundation Trust","startDate":"2023-02-02","conditions":["Kidney Transplant","Kidney Disease, Chronic"],"enrollment":100,"completionDate":"2024-12-12"},{"nctId":"NCT07177183","phase":"NA","title":"Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure","status":"RECRUITING","sponsor":"University Hospital Ostrava","startDate":"2026-02-02","conditions":["Prolonged Mechanical Ventilation","Critical Illness"],"enrollment":492,"completionDate":"2028-02-02"},{"nctId":"NCT06712407","phase":"PHASE4","title":"Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy","status":"RECRUITING","sponsor":"Calliditas Therapeutics AB","startDate":"2024-12-17","conditions":["IgA Nephropathy"],"enrollment":60,"completionDate":"2027-11"},{"nctId":"NCT04855422","phase":"","title":"Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2021-07-14","conditions":["Transplant; Complication, Rejection"],"enrollment":42,"completionDate":"2026-06"},{"nctId":"NCT07343830","phase":"","title":"Prediction of Acute Kidney Injury After Cardiac Surgery With Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2026-01-30","conditions":["Acute Kidney Injury","Cardiac Surgery","Cardiopulmonary Bypass Surgery","Cardiac Surgery Associated - Acute Kidney Injury"],"enrollment":455,"completionDate":"2026-02-02"},{"nctId":"NCT06126601","phase":"","title":"Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety","status":"RECRUITING","sponsor":"Technische Universität Dresden","startDate":"2023-07-18","conditions":["Pancreatectomy","Hyperamylasemia","Pancreatitis, Acute"],"enrollment":150,"completionDate":"2026-07"},{"nctId":"NCT07377786","phase":"","title":"Study of Prognostic Values of Platelet Indices and Inflammatory Markers in Patients With HELLP Syndrome.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-02-01","conditions":["HELLP Syndrome"],"enrollment":60,"completionDate":"2026-12"},{"nctId":"NCT03459846","phase":"PHASE2","title":"A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2018-03-16","conditions":["Urinary Bladder Neoplasms"],"enrollment":154,"completionDate":"2026-12-31"},{"nctId":"NCT04680728","phase":"","title":"Venous Congestion and Organ Dysfunction.","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2020-10-06","conditions":["Venous Congestion","Organ Dysfunction Syndrome"],"enrollment":185,"completionDate":"2022-11-14"},{"nctId":"NCT02943746","phase":"NA","title":"Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2016-11","conditions":["Premature Infants"],"enrollment":118,"completionDate":"2021-04-30"},{"nctId":"NCT04986254","phase":"","title":"PNEUmonia DOSing in Critically Ill Patients (PNEUDOS)","status":"COMPLETED","sponsor":"The University of Queensland","startDate":"2019-10-17","conditions":["Pneumonia"],"enrollment":179,"completionDate":"2024-01-31"},{"nctId":"NCT03534934","phase":"NA","title":"CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPD","status":"COMPLETED","sponsor":"Punam K Saha","startDate":"2019-02-26","conditions":["Pulmonary Disease, Chronic Obstructive","Osteoporosis"],"enrollment":560,"completionDate":"2025-03-19"},{"nctId":"NCT03159702","phase":"PHASE2","title":"Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2017-12-08","conditions":["Hematological Malignancy","Multiple Myeloma"],"enrollment":43,"completionDate":"2025-12-08"},{"nctId":"NCT05283213","phase":"","title":"Development of an Innovative Clinico-biological Score for the Early Detection of Acute Renal Failure Associated With Cardiac Surgery.","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2022-11-22","conditions":["Acute Kidney Injury"],"enrollment":400,"completionDate":"2025-03-10"},{"nctId":"NCT04793152","phase":"NA","title":"Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC","status":"RECRUITING","sponsor":"Anthony Bai","startDate":"2023-03-20","conditions":["MRSA"],"enrollment":700,"completionDate":"2029-10"},{"nctId":"NCT05344599","phase":"","title":"Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2022-01-19","conditions":["Postural Orthostatic Tachycardia Syndrome","Acute Hepatic Porphyria"],"enrollment":70,"completionDate":"2026-06-30"},{"nctId":"NCT06114498","phase":"","title":"Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Medical Research Center for Therapy and Preventive Medicine","startDate":"2023-09-01","conditions":["Heart Failure With Preserved Ejection Fraction","Obesity, Mild","Decompensated Heart Failure"],"enrollment":240,"completionDate":"2026-07-31"},{"nctId":"NCT07297433","phase":"NA","title":"Erector Spinae Plane Block in Laparoscopic Colorectal Cancer Surgery","status":"RECRUITING","sponsor":"Kayseri City Hospital","startDate":"2025-01-05","conditions":["Kolon Kanseri"],"enrollment":60,"completionDate":"2026-04-15"},{"nctId":"NCT07356193","phase":"NA","title":"Serum CPK and Creatinine Changes During Plyometric Training in Collegiate Athletes","status":"COMPLETED","sponsor":"Batterjee Medical College","startDate":"2022-02-13","conditions":["Muscle Damage","Plyometric Exercises","Creatine Kinase","Exercise Physiology"],"enrollment":62,"completionDate":"2022-12-28"},{"nctId":"NCT04440358","phase":"PHASE1,PHASE2","title":"Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM","status":"COMPLETED","sponsor":"InSightec","startDate":"2020-10-13","conditions":["Recurrent Glioblastoma"],"enrollment":13,"completionDate":"2023-12-31"},{"nctId":"NCT07352319","phase":"NA","title":"DOES LOWER BODY PLYOMETRICS CAUSE RHABDOMYOLYSIS IN FEMALE VOLLEYBALL PLAYERS-AN EXPERIMENTAL STUDY","status":"COMPLETED","sponsor":"Cairo University","startDate":"2022-01-12","conditions":["Exercise-Induced Muscle Damage","Rhabdomyolysis","Athletes"],"enrollment":60,"completionDate":"2022-10-25"},{"nctId":"NCT07349342","phase":"NA","title":"Stable Versus Unstable Resistance Training Effects on Physical Fitness and Physiological Biomarkers of Untrained Male University Students","status":"ACTIVE_NOT_RECRUITING","sponsor":"Addis Ababa University","startDate":"2025-11-12","conditions":["No Condition","Health Young Males"],"enrollment":54,"completionDate":"2026-02"},{"nctId":"NCT07348484","phase":"","title":"Urinary Biomarker-Based Diagnostic and Monitoring System for Chronic Kidney Disease and Real-World Effectiveness of SGLT2 Inhibitors","status":"NOT_YET_RECRUITING","sponsor":"Instituto de Investigación Biomédica de Salamanca","startDate":"2026-01","conditions":["Chronic Kidney Disease"],"enrollment":300,"completionDate":"2028-03"},{"nctId":"NCT07343531","phase":"NA","title":"A Study Of Moderately Hypo-Fractionated External-beam Radiotherapy With Concurrent Chemotherapy and High Dose Rate Brachytherapy In Cervical Cancer","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-07-01","conditions":["Cervical Carcinoma Stage III","Cervical Carcinoma Stage IIB","Cervical Carcinoma Stage II"],"enrollment":30,"completionDate":"2027-06-30"},{"nctId":"NCT07342387","phase":"NA","title":"Development of Microfluidic Patch-type Sweat Sensor","status":"COMPLETED","sponsor":"Korea University","startDate":"2024-06-15","conditions":["Diseases of the Genitourinary System"],"enrollment":5,"completionDate":"2026-01-07"},{"nctId":"NCT03968393","phase":"PHASE4","title":"Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-06-14","conditions":["Stroke","Atrial Fibrillation"],"enrollment":2270,"completionDate":"2028-12"},{"nctId":"NCT04659876","phase":"","title":"Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to Coronavirus Disease 2019","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital","startDate":"2020-03-22","conditions":["Covid19 and Mortality"],"enrollment":445,"completionDate":"2020-12-08"},{"nctId":"NCT07329959","phase":"PHASE1","title":"CAR-DC for End-Stage IPF","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-02-01","conditions":["Idiopathic Pulmonary Fibrosis(IPF)"],"enrollment":8,"completionDate":"2029-02-28"},{"nctId":"NCT07328113","phase":"","title":"Interleukin-6 and Thyroid Dysfunction in Hemodialysis Patients","status":"COMPLETED","sponsor":"Dr. Soetomo General Hospital","startDate":"2023-11-14","conditions":["Chronic Kidney Disease on Hemodialysis","Thyroid Gland Disease"],"enrollment":65,"completionDate":"2024-06-30"},{"nctId":"NCT04844801","phase":"NA","title":"Rate, Rhythm or Risk Control for New-onset Supraventricular Arrhythmia During Septic Shock: a Randomized Controlled Trial","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-11-09","conditions":["Supraventricular Arrhythmia","Septic Shock"],"enrollment":240,"completionDate":"2026-03"},{"nctId":"NCT07321509","phase":"PHASE4","title":"Digoxin After Acute Heart Failure","status":"RECRUITING","sponsor":"Guillermo Liniado","startDate":"2025-12-16","conditions":["Acute Heart Failure (AHF)"],"enrollment":120,"completionDate":"2028-12-16"},{"nctId":"NCT07318584","phase":"PHASE2","title":"Cefotetan Therapy for Escherichia Coli Infections","status":"NOT_YET_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2026-03","conditions":["E Coli Infection","ESBL Producing E.Coli"],"enrollment":84,"completionDate":"2028-08"},{"nctId":"NCT07099157","phase":"PHASE4","title":"Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster","status":"RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2025-08-25","conditions":["Herpes Zoster"],"enrollment":140,"completionDate":"2027-12-31"},{"nctId":"NCT05472883","phase":"NA","title":"Identification of Human Biomarkers Predictive of Diabetes Remission in Type 2 Diabetes Patient (BARIAKINES)","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2023-02-27","conditions":["Type 2 Diabetes"],"enrollment":50,"completionDate":"2025-12-31"},{"nctId":"NCT07149610","phase":"NA","title":"Connected Care for Type 2 Diabetes Self-Management","status":"RECRUITING","sponsor":"Marche Region Regional Health Agency","startDate":"2025-10-13","conditions":["Diabetes Type 2"],"enrollment":388,"completionDate":"2026-12-31"},{"nctId":"NCT07305324","phase":"NA","title":"Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI","status":"NOT_YET_RECRUITING","sponsor":"Yale University","startDate":"2026-06-15","conditions":["MASLD","Fibrosis of Liver"],"enrollment":40,"completionDate":"2027-06-15"},{"nctId":"NCT06006117","phase":"PHASE3","title":"Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma","status":"RECRUITING","sponsor":"The Lymphoma Academic Research Organisation","startDate":"2023-09-05","conditions":["Marginal Zone Lymphoma"],"enrollment":260,"completionDate":"2032-09"},{"nctId":"NCT04481919","phase":"PHASE2","title":"Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2022-05-01","conditions":["Heart Failure","Acute Heart Failure"],"enrollment":474,"completionDate":"2026-12-31"},{"nctId":"NCT03013998","phase":"PHASE1,PHASE2","title":"Study of Biomarker-Based Treatment of Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Beat AML, LLC","startDate":"2016-11","conditions":["Previously Untreated Relapsed Refractory Acute Myeloid Leukemia"],"enrollment":3000,"completionDate":"2028-12"},{"nctId":"NCT04045093","phase":"PHASE4","title":"Dabigatran for Mitral Stenosis Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2020-10-22","conditions":["Atrial Fibrillation","Mitral Stenosis"],"enrollment":370,"completionDate":"2027-09-30"},{"nctId":"NCT07285421","phase":"NA","title":"Renal and Vascular Phenotypic Characterization of Patients With Enamel Renal Syndrome Due to a Pathogenic Variant of the FAM20A Gene and Pathophysiological Study of Ectopic Calcifications","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-01-01","conditions":["Enamel Renal Syndrome"],"enrollment":30,"completionDate":"2029-10-30"},{"nctId":"NCT07129473","phase":"PHASE2","title":"Hyperemesis Gravidarum Risk Reduction With Metformin","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2026-01","conditions":["Hyperemesis Gravidarum"],"enrollment":224,"completionDate":"2031-01"},{"nctId":"NCT07275541","phase":"","title":"Platelet Aggregation in the Diagnosis of Acute Graft Rejection","status":"RECRUITING","sponsor":"University Hospital, Martin","startDate":"2024-11-26","conditions":["Platelet Aggregation","Kidney Transplant Rejection"],"enrollment":60,"completionDate":"2027-11-26"},{"nctId":"NCT06698614","phase":"","title":"MEMRI and Kidney Disease","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2024-11-07","conditions":["Acute Kidney Injury","Kidney Transplant","Vasculitis","Chronic Kidney Disease(CKD)"],"enrollment":120,"completionDate":"2029-11-07"},{"nctId":"NCT05781750","phase":"PHASE2","title":"A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)","status":"TERMINATED","sponsor":"Kezar Life Sciences, Inc.","startDate":"2023-11-03","conditions":["Lupus Nephritis"],"enrollment":84,"completionDate":"2024-11-08"},{"nctId":"NCT04163432","phase":"PHASE2","title":"Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2020-06-16","conditions":["Non-Small Cell Lung Cancer Metastatic"],"enrollment":43,"completionDate":"2026-12"},{"nctId":"NCT06574789","phase":"PHASE2","title":"Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)","status":"RECRUITING","sponsor":"Murdoch Childrens Research Institute","startDate":"2024-10-29","conditions":["Cytomegalovirus Viraemia"],"enrollment":232,"completionDate":"2028-12"},{"nctId":"NCT07258706","phase":"","title":"Demographic and Interpopulation Variations in Evaluation and Results of TAVI","status":"ENROLLING_BY_INVITATION","sponsor":"Poznan University of Medical Sciences","startDate":"2025-01-01","conditions":["Aortic Stenosis","TAVI(Transcatheter Aortic Valve Implantation)","Computed Tomography","Inflammatory Response During Cardiac Surgery","Inflammation"],"enrollment":800,"completionDate":"2028-12"},{"nctId":"NCT05975307","phase":"PHASE2","title":"Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-12-01","conditions":["Muscle-Invasive Bladder Carcinoma","Programmed Cell Death Protein 1 Inhibitor","Radiotherapy"],"enrollment":71,"completionDate":"2029-12-31"},{"nctId":"NCT07256613","phase":"NA","title":"Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"Dow University of Health Sciences","startDate":"2025-08-15","conditions":["Type 2 Diabetes Mellitus MeSH:D003924","Periodontitis MeSH:D010518","Diabetic Nephropathies MeSH:D003928"],"enrollment":46,"completionDate":"2026-04-15"},{"nctId":"NCT07251075","phase":"","title":"Clinical Performance of a Point-of-Care Creatinine Testing System in Individuals With Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Tingting Xu","startDate":"2025-11-30","conditions":["Chronic Kidney Diseases","Kidney Injury, Acute"],"enrollment":200,"completionDate":"2025-12-30"},{"nctId":"NCT02810743","phase":"PHASE3","title":"Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2017-01-25","conditions":["Breast Cancer"],"enrollment":174,"completionDate":"2033-12-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral"},"crossReferences":{"UNII":"2P3VWU3H10","SPL_ID":"9cfee475-afb6-479b-a552-240f97fb29a7","chemblId":"CHEMBL65567"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"BioActive Nutritional, Inc.","relationship":"Original Developer"}],"publicationCount":155237,"therapeuticAreas":["Nephrology"],"biosimilarFilings":[],"originalDeveloper":"BioActive Nutritional, Inc.","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"BioActive Nutritional, Inc.","companyId":"bioactive-nutritional-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:18:12.214232+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}